GCM
LLY icon

Gladius Capital Management’s Eli Lilly LLY Stock Holding History

Gladius Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111M Buy
92,700
+67,500
+268% +$69M 6.73% 4
2026
Q1 		$23.2M Buy
25,200
+6,700
+36% +$6.79M 1.03% 23
2025
Q4 		$19.9M Buy
18,500
+11,400
+161% +$10.9M 1.09% 24
2025
Q3 		$5.42M Buy
+7,100
New +$5.28M 0.57% 41
2024
Q1 		– Sell
-4,300
Closed -$2.51M – 370
2023
Q4 		$2.51M Sell
4,300
-8,500
-66% -$4.96M 0.39% 57
2023
Q3 		$6.88M Buy
12,800
+4,600
+56% +$2.37M 0.29% 69
2023
Q2 		$3.85M Buy
8,200
+2,000
+32% +$839K 0.19% 56
2023
Q1 		$2.13M Buy
+6,200
New +$2.09M 0.12% 83

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Gladius Capital Management's LLY Position: Q2 2026 in Review

Gladius Capital Management sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 3,400 shares — an estimated $3.47M sold.

Gladius Capital Management first reported a position in LLY in Q4 2021 and held it in 16 quarters. The position peaked at $6.09M in Q4 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Gladius Capital Management reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Gladius Capital Management sold 3,400 Eli Lilly shares in Q2 2026, an estimated $3.47M.
  • Gladius Capital Management first reported a position in Eli Lilly in Q4 2021 and held it in 16 quarters.
  • Gladius Capital Management's Eli Lilly position peaked at $6.09M in Q4 2024.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Gladius Capital Management's 13F filing for Q2 2026, filed 30 Jul 2026.